furthermore , diazoxide therapy in two patients caused a mild but consistent decrease in the number of insulin receptor sites , and the institution of continuous nocturnal nasogastric feedings in a patient with glycogen storage disease type i was followed by amelioration of the hypoglycemia and a marked increase in 125i-insulin specific binding from 5.2 to 9.5 % .
C0012022
diazoxide
C0020615
hypoglycemia